Dubrow, who appears on the July 2, 2026 cover of of Womans World magazine, where he shares the latest on retatrutide and GLP-1 drugs
It takes a few weeks for the body to adjust to the medication and show visible weight loss, after which most patients lose 1-3 pounds per week
The safety and pharmacokinetic characteristics of long-term local application of GLP-1RAs in human joints still need to be further evaluated, which is crucial for its transformation from the laboratory to the clinic
Do Semaglutide GLP-1, Mounjaro, Wegovy, and Ozempic help keep weight off long term
The FDAs grace period for manufacturers to stop producing and selling compounded tirzepatide is over, and the cut-off date for semaglutide is May 22
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors